(S)-nicotine increases expression ISO S100A14 (Homo sapiens) 6480464 Nicotine results in increased expression of S100A14 mRNA CTD PMID:23825647 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of S100A14 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of S100A14 mRNA] CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of S100A14 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of S100A14 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO S100A14 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of S100A14 mRNA CTD PMID:20823114 17beta-estradiol multiple interactions ISO S100a14 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of S100A14 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions ISO S100a14 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of S100A14 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of S100A14 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of S100A14 mRNA CTD PMID:21570461 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of S100A14 mRNA CTD PMID:17317680 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of S100A14 mRNA CTD PMID:33297965 5-azacytidine decreases expression ISO S100A14 (Homo sapiens) 6480464 Azacitidine results in decreased expression of S100A14 mRNA CTD PMID:20823114 aflatoxin B1 decreases expression ISO S100A14 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of S100A14 mRNA CTD PMID:27153756 aflatoxin B1 increases expression ISO S100A14 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of S100A14 mRNA CTD PMID:32234424 aflatoxin B1 increases methylation ISO S100A14 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of S100A14 gene CTD PMID:27153756 aldehydo-D-glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol more ... CTD PMID:37567420 all-trans-retinoic acid decreases expression ISO S100A14 (Homo sapiens) 6480464 Tretinoin results in decreased expression of S100A14 mRNA CTD PMID:23830798 aristolochic acid A increases expression ISO S100A14 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of S100A14 mRNA CTD PMID:33212167 arsenous acid decreases response to substance ISO S100A14 (Homo sapiens) 6480464 S100A14 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of S100A14 mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO S100A14 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of S100A14 mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO S100A14 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of S100A14 5' UTR and Benzo(a)pyrene results in decreased methylation of S100A14 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of S100A14 mRNA CTD PMID:27858113 benzo[b]fluoranthene increases expression EXP 6480464 benzo(b)fluoranthene results in increased expression of S100A14 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of S100A14 mRNA CTD PMID:27858113 bis(2-ethylhexyl) phthalate increases expression ISO S100A14 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of S100A14 mRNA CTD PMID:28412506 bisphenol A decreases expression ISO S100a14 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of S100A14 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of S100A14 mRNA CTD PMID:32156529 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of S100A14 mRNA CTD PMID:32370801 bucladesine multiple interactions ISO S100A14 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of S100A14 mRNA CTD PMID:20823114 butanal increases expression ISO S100A14 (Homo sapiens) 6480464 butyraldehyde results in increased expression of S100A14 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO S100A14 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of S100A14 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO S100A14 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of S100A14 mRNA CTD PMID:35301059 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of S100A14 mRNA CTD PMID:33711761 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of S100A14 mRNA CTD PMID:37019170 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of S100A14 mRNA CTD PMID:20938992 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of S100A14 mRNA CTD PMID:28472532 chrysene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of S100A14 mRNA CTD PMID:27858113 cobalt atom increases expression EXP 6480464 Cobalt results in increased expression of S100A14 mRNA CTD PMID:34468815 copper(II) sulfate increases expression ISO S100A14 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of S100A14 mRNA CTD PMID:19549813 cyclosporin A increases expression ISO S100A14 (Homo sapiens) 6480464 Cyclosporine results in increased expression of S100A14 mRNA CTD PMID:25562108 and PMID:33631201 D-glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol more ... CTD PMID:37567420 diarsenic trioxide decreases response to substance ISO S100A14 (Homo sapiens) 6480464 S100A14 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 dibenz[a,h]anthracene decreases expression EXP 6480464 1 more ... CTD PMID:26377693 dicrotophos decreases expression ISO S100A14 (Homo sapiens) 6480464 dicrotophos results in decreased expression of S100A14 mRNA CTD PMID:28302478 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of S100A14 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO S100A14 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 ethanol multiple interactions ISO S100A14 (Homo sapiens) 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of S100A14 mRNA CTD PMID:29432896 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of S100A14 mRNA more ... CTD PMID:20938992 and PMID:22206623 fructose multiple interactions EXP 6480464 [lard co-treated with Cholesterol more ... CTD PMID:37567420 glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol more ... CTD PMID:37567420 herbicide multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of S100A14 mRNA CTD PMID:37567420 hydrogen peroxide affects expression ISO S100A14 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of S100A14 mRNA CTD PMID:20044591 isobutanol multiple interactions ISO S100A14 (Homo sapiens) 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of S100A14 mRNA CTD PMID:29432896 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of S100A14 mRNA CTD PMID:20938992 medroxyprogesterone acetate multiple interactions ISO S100A14 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of S100A14 mRNA CTD PMID:20823114 mercury dibromide increases expression ISO S100A14 (Homo sapiens) 6480464 mercuric bromide results in increased expression of S100A14 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO S100A14 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A14 mRNA CTD PMID:27188386 N-Nitrosopyrrolidine increases expression ISO S100A14 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in increased expression of S100A14 mRNA CTD PMID:32234424 naphthalene increases expression EXP 6480464 naphthalene results in increased expression of S100A14 mRNA CTD PMID:18978301 nickel atom increases expression ISO S100A14 (Homo sapiens) 6480464 Nickel results in increased expression of S100A14 mRNA CTD PMID:25583101 nicotine increases expression ISO S100A14 (Homo sapiens) 6480464 Nicotine results in increased expression of S100A14 mRNA CTD PMID:23825647 O-methyleugenol increases expression ISO S100A14 (Homo sapiens) 6480464 methyleugenol results in increased expression of S100A14 mRNA CTD PMID:32234424 oxaliplatin increases expression ISO S100A14 (Homo sapiens) 6480464 oxaliplatin results in increased expression of S100A14 mRNA CTD PMID:16510598 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of S100A14 mRNA more ... CTD PMID:20826374 more ... ozone increases expression EXP 6480464 Ozone results in increased expression of S100A14 mRNA CTD PMID:20826374 more ... p-chloromercuribenzoic acid increases expression ISO S100A14 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in increased expression of S100A14 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO S100A14 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A14 mRNA CTD PMID:27188386 perfluorononanoic acid increases expression ISO S100A14 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in increased expression of S100A14 mRNA CTD PMID:32588087 perfluorooctanoic acid increases expression ISO S100A14 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of S100A14 protein CTD PMID:26879310 phenobarbital affects expression ISO S100A14 (Homo sapiens) 6480464 Phenobarbital affects the expression of S100A14 mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO S100A14 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of S100A14 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO S100A14 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A14 mRNA CTD PMID:27188386 phosgene affects expression EXP 6480464 Phosgene affects the expression of S100A14 mRNA CTD PMID:16300373 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of S100A14 mRNA CTD PMID:22238285 resveratrol multiple interactions ISO S100A14 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of S100A14 mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO S100A14 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite increases expression ISO S100A14 (Homo sapiens) 6480464 sodium arsenite results in increased expression of S100A14 mRNA CTD PMID:34032870 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of S100A14 mRNA CTD PMID:17555576 testosterone multiple interactions ISO S100a14 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of S100A14 mRNA CTD PMID:32741896 tetraphene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of S100A14 mRNA CTD PMID:27858113 thapsigargin increases expression ISO S100A14 (Homo sapiens) 6480464 Thapsigargin results in increased expression of S100A14 mRNA CTD PMID:29453283 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of S100A14 mRNA CTD PMID:23409001 titanium dioxide increases expression ISO S100a14 (Rattus norvegicus) 6480464 titanium dioxide results in increased expression of S100A14 mRNA CTD PMID:30012374 titanium dioxide affects expression EXP 6480464 titanium dioxide affects the expression of S100A14 mRNA CTD PMID:23557971 tris(2-butoxyethyl) phosphate affects expression ISO S100A14 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of S100A14 mRNA CTD PMID:29024780 tunicamycin increases expression ISO S100A14 (Homo sapiens) 6480464 Tunicamycin results in increased expression of S100A14 mRNA CTD PMID:29453283 valproic acid increases expression ISO S100A14 (Homo sapiens) 6480464 Valproic Acid results in increased expression of S100A14 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO S100A14 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A14 mRNA CTD PMID:27188386 zoledronic acid decreases expression ISO S100A14 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of S100A14 mRNA CTD PMID:24714768